Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: roche + survival + improves  Related to the article below (Last Update: 8/4/2008)

Effective Treatment of Pancreatic Cancer Remains Elusive
Abkhazia, CA - Jul 15, 2008
"Treatment with gemcitabine greatly improved disease-free survival...and doubled overall survival," said investigator Helmut Oettle, MD, PhD, Charit? School ...
Roche posts very good results: strong market outperformance ...
Business-News, Switzerland - Jul 20, 2008
Improved survival of transplant patients means that they are taking immunosuppressant therapy for longer, and this is reflected in a steady increase in ...
OSI Pharmaceuticals Announces Second Quarter 2008 Financial Results
MarketWatch - Jul 23, 2008
... inhibitor to have demonstrated the ability to improve survival in both non-small cell lung cancer and pancreatic cancer patients in certain settings. ...OSIP - DNA
Halozyme Therapeutics Announces Positive Findings With Pegylated ...
Medical News Today (press release), UK - Jul 23, 2008
Survival benefit demonstrated. Two different combination dosage regimens of PEGPH20 plus docetaxel demonstrated improved survival compared to the control ...HALO
The many contradictions of Le Corbusier
guardian.co.uk, UK - Jul 17, 2008
Take, for instance, one of the first fully realised projects of his career, the Villa La Roche in Paris. Built in 1925, it is widely regarded as the first ...
OSI Pharmaceuticals Begins Clinical Development Program for OSI ...
Business Wire (press release), CA - Jul 15, 2008
... inhibitor to have demonstrated the ability to improve survival in both non-small cell lung cancer and pancreatic cancer patients in certain settings. ...OSIP
LabCorp?s Q2 Revenues Grow, But Limp US Economy Tempers 2008 ...
Pharmacogenomics Reporter (subscription), NY - Jul 30, 2008
In February, Roche acquired Ventana Medical Systems, a tissue diagnostics company. And as reported by Pharmacogenomics Reporter last week, ...
OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday ...
Trading Markets (press release), CA - Jul 22, 2008
The prevalence of HF is expected to continue increasing due to the aging population and improved survival rates of patients with other cardiovascular ...PINK:LLSR - OTC:FMNJ - OTC:IVIT
GlaxoSmithKline: NICE says no to Tyverb
Trading Markets (press release), CA - Jul 8, 2008
The UK panel ruled that, based on data showing that the median survival time for women who received Tyverb (lapatinib) along with Roche's Xeloda ...
Pharmacotherapeutic Options for the Treatment of Depression in ...
RedOrbit, TX - Jul 20, 2008
Although it appears that depression is associated with decreased overall survival in patients with CKD, it is unclear if depression is an independent risk ...
Source: Google News

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter … -
… A Pariente, JM Perarnau, J Roche, M Scribe-Outtas … - Gastroenterology, 2002 - Elsevier
... ttt JEAN-MARC PERARNAU,???? JEAN ROCHE, IIIIIIII MYRIAM ... the administration of
terlipressin improves renal func- tion, its effect on survival is unknown ...

Adjuvant Chemotherapy Improves Survival After Liver Transplantation for Hepatocellular Carcinoma. -
KM Olthoff, MH Rosove, CR Shackleton, DK Imagawa, … - Annals of Surgery, 1995 - pubmedcentral.nih.gov
... provide long-term cure and may improve survival, even in ... Prolonged survival after
liver transplantation and cancer ... D, Miglietta C, Cauquil P, Roche A. Primary ...

Disease-Free Survival Advantage of Weekly Epirubicin Plus Tamoxifen Versus Tamoxifen Alone As … -
P Fargeot, J Bonneterre, H Roche, A Lortholary, M … - Journal of Clinical Oncology, 2004 - jco.ascopubs.org
... carefully. Nevertheless, we demonstrate that this schedule of EPI-TAM improves
disease-free survival relative to TAM alone. A part ...

… CD95/Fas Ligand-Mediated Apoptosis and Improves Liver Allograft Survival via Carbon Monoxide … -
B Ke, R Buelow, XD Shen, J Melinek, F Amersi, F … - Human Gene Therapy, 2002 - liebertonline.com
... nick-end labeling) reaction mixture (50 ml/well) (Roche Molecular Biochemicals ...
Ad-HO-1 gene transfer prolongs allogeneic OLT survival, improves hepatic function ...

Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831 -
PC Roche, VJ Suman, RB Jenkins, NE Davidson, S … - jnci, 2002 - jnci.oxfordjournals.org
... 4 Perez EA, Roche PC, Jenkins RB, Reynolds CA, Halling KC, Ingle JN, et al. ... 6 Mass
RD, Press M, Anderson S, Murphy M, Slamon D. Improved survival benefit from ...

Management of the Hepatitis B Virus in the Liver Transplantation Setting: A European and an American … -
N Terrault, B Roche, D Samuel - survival - doi.wiley.com
... Perspective Norah Terrault, 1 Bruno Roche, 2 and Didier Samuel 2 ... 1,2 Survival
significantly improved with use of HBIG prophylaxis. ...

… oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal … -
M WAGNER, P CADETG, R RUF, L MAZZUCCHELLI, P … - Kidney International, 2003 - pt.wkhealth.com
... the induction of HO-1 improves the outcome ... Survival and graft function, which were
observed until ... were performed using a commercial kit (Roche Diagnostic, Basel ...

Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle … -
SM Pulido, AC Passaquin, WJ Leijendekker, C … - FEBS Letters, 1998 - Elsevier
... Ca 2+ influx, or to improved sarcoplasmic (SR ... improvement in mdx muscle cell survival
and Ca 2 ... Fran?aise contre les Myopathies, the Roche Research Foundation ...

Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, … -
R Lundblad, JM Nesland, KE Giercksky - Critical Care Medicine, 1996 - ccmjournal.com
... 1.25 mg/mL) (Dormicum Registered Trademark, Hoffmann-La Roche, Basel, Switzerland). ...
G-CSF subgroups, and these groups all had improved survival rates compared ...

… (CMV) DNA Load Is an Independent Predictor of CMV Disease and Survival in Advanced AIDS -
SA Spector, K Hsia, M Crager, M Pilcher, S Cabral, … - Journal of Virology, 1999 - pubmedcentral.nih.gov
... HIV-1 RNA was quantified with the standard Roche Amplicor assay (25 ... in a decline
of plasma CMV DNA to undetectable levels, is associated with improved survival. ...

Source: Google Scholar
 
 

Roche says MabThera improves non-Hodgkin survival

Last Updated: 2006-12-12 14:41:33 -0400 (Reuters Health)

ZURICH - Roche Holding AG said on Tuesday its MabThera cancer drug showed improved survival rates for first-line non-Hodgkin's lymphoma patients in phase III clinical trials.

The study showed MabThera, which is already approved to treat non-Hodgkin's lymphoma, significantly improved overall survival rates in combination with chemotherapy when compared to chemotherapy alone, Roche said. MabThera -- known as Rituxan in the United States, where it is sold by Roche's partners Genentech inc. and Biogen Idec -- is already the Swiss company's biggest seller, raking in 4 billion Swiss francs ($3.32 billion) as a cancer therapy last year. MabThera is a monoclonal antibody that binds to B-cells that cause lymphoma, recruiting the body's own defences to kill them.

Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With:News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 

 © 2002-2006

Keywords::

Contact Iconocast

Home Page